These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3162734)

  • 21. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C.
    Bakker HM; Tans G; Janssen-Claessen T; Thomassen MC; Hemker HC; Griffin JH; Rosing J
    Eur J Biochem; 1992 Aug; 208(1):171-8. PubMed ID: 1387359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane binding properties of blood coagulation Factor V and derived peptides.
    Pusey ML; Nelsestuen GL
    Biochemistry; 1984 Dec; 23(25):6202-10. PubMed ID: 6441598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of factor Va by plasmin.
    Omar MN; Mann KG
    J Biol Chem; 1987 Jul; 262(20):9750-5. PubMed ID: 2954962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of prothrombinase complex by plasma proteinase inhibitors.
    Ellis V; Scully MF; Kakkar VV
    Biochemistry; 1984 Nov; 23(24):5882-7. PubMed ID: 6335402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane penetration of bovine factor V and Va detected by labeling with 5-iodonaphthalene-1-azide.
    Lecompte MF; Krishnaswamy S; Mann KG; Nesheim ME; Gitler C
    J Biol Chem; 1987 Feb; 262(5):1935-7. PubMed ID: 3818583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex.
    Husten EJ; Esmon CT; Johnson AE
    J Biol Chem; 1987 Sep; 262(27):12953-61. PubMed ID: 3477541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulation.
    Giles AR; Nesheim ME; Mann KG
    J Clin Invest; 1984 Dec; 74(6):2219-25. PubMed ID: 6439744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of enzyme and substrate binding in the prothrombinase complex.
    Tucker MM; Nesheim ME; Mann KG
    Biochemistry; 1983 Sep; 22(19):4540-6. PubMed ID: 6626514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into the complex association of bovine factor Va with acidic-lipid-containing synthetic membranes.
    Cutsforth GA; Koppaka V; Krishnaswamy S; Wu JR; Mann KG; Lentz BR
    Biophys J; 1996 Jun; 70(6):2938-49. PubMed ID: 8744332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of bone Gla protein (osteocalcin) with phospholipid vesicles.
    Gendreau MA; Krishnaswamy S; Mann KG
    J Biol Chem; 1989 Apr; 264(12):6972-8. PubMed ID: 2785110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine.
    Comfurius P; Smeets EF; Willems GM; Bevers EM; Zwaal RF
    Biochemistry; 1994 Aug; 33(34):10319-24. PubMed ID: 8068668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet factor Xa receptor.
    Tracy PB; Nesheim ME; Mann KG
    Methods Enzymol; 1992; 215():329-60. PubMed ID: 1331708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex.
    van Rijn JL; Govers-Riemslag JW; Zwaal RF; Rosing J
    Biochemistry; 1984 Sep; 23(20):4557-64. PubMed ID: 6498156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the membrane surface in the activation of human coagulation factor X.
    Krishnaswamy S; Field KA; Edgington TS; Morrissey JH; Mann KG
    J Biol Chem; 1992 Dec; 267(36):26110-20. PubMed ID: 1464622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of factor Va heavy and light chains in protein and lipid rearrangements associated with the formation of a bovine factor Va-membrane complex.
    Koppaka V; Talbot WF; Zhai X; Lentz BR
    Biophys J; 1997 Nov; 73(5):2638-52. PubMed ID: 9370458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of membrane fluidity and fatty acid composition on the prothrombin-converting activity of phospholipid vesicles.
    Govers-Riemslag JW; Janssen MP; Zwaal RF; Rosing J
    Biochemistry; 1992 Oct; 31(41):10000-8. PubMed ID: 1390758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteolytic alterations of factor Va bound to platelets.
    Tracy PB; Nesheim ME; Mann KG
    J Biol Chem; 1983 Jan; 258(1):662-9. PubMed ID: 6848522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family.
    Tait JF; Gibson D; Fujikawa K
    J Biol Chem; 1989 May; 264(14):7944-9. PubMed ID: 2524476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.